Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateNew MexicoIntroduced
SB 33: RIGHT TO TRY INDIVIDUALIZED TREATMENTS ACT
Jeff Steinborn
SB 33 status: Introduced — action postponed indefinitely (updated Mar 24, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
52OUT OF 100
Score:52/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 45/100
Constitutionality50%
Bipartisan50%
Public opinion50%
Bill summary
What changes
The bill establishes a state-level 'Right to Try' framework, permitting patients with life-threatening conditions to access medical treatments that have not yet received full government approval.
Who is affected
Patients with life-threatening illnesses, medical providers, and healthcare facilities providing experimental treatments.
Requirements and enforcement
Not stated in the available source.
Costs and funding
Not stated; potentially impacts insurance premiums and medical liability costs.
When it takes effect
Legislative action has been postponed indefinitely.
Potential benefits
Potential for increased access to experimental care and patient autonomy in end-of-life decision-making.
Risks and tradeoffs
Risk of unverified safety, potential for exploitation, and medical practice liability concerns.
What is still unknown
Specific mechanisms for oversight, patient protection, and long-term reporting requirements are not detailed in the summary.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
55%
Benefits
- Potential new market for personalized medical treatments
- Encourages R&D for rare and customized medicine
- Supports growth in specialized biotech sectors
Risks
- Potential for increased medical malpractice liability
- Higher direct healthcare costs for patients
- Regulatory uncertainty for medical providers
Society
Positive outlook
60%
Benefits
- Grants bodily autonomy to terminal patients
- Provides hope when standard options are exhausted
- Allows for personalized medical approaches
Risks
- Risk of false hope for vulnerable patients
- Potential for exploitation by medical actors
- Lack of rigorous, peer-reviewed evidence for outcomes
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Critical outlook
40%
Benefits
- Expands access to potentially life-saving interventions
- Allows clinical innovation for unmet medical needs
- Broadens definition of accessible medical care
Risks
- Significant safety risks from unverified treatments
- Absence of standard FDA-level safety oversight
- Potential for dangerous side effects in experimental use
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
Significant patient safety risks exist due to the use of experimental, unapproved therapies.
Analysis scope
Source provided is limited to a brief summary.
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.